Cystic fibrosis diabetes in adult;Le diabète de la mucoviscidose chez l'adulte

Annales d'Endocrinologie

Volumn 66, Issue 4, 2005, Pages 347-354

  Vantyghem, M C ^a   Moussaid Guennoun R ^b   Perimenis, P ^b   Marcelli Tourvieille, S ^b   Perez, T ^b   Wallaert, B ^b  

^a Centre Hospitalier et Universitaire   (France)

^b NONE

Author keywords

Adult; Cystic fibrosis; Diabetes; OGTT

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AUTOSOMAL RECESSIVE DISORDER; CFTR GENE; CYSTIC FIBROSIS; DIABETES MELLITUS; FRANCE; GENE; GENE MUTATION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; LUNG FUNCTION; NUTRITIONAL STATUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS INSUFFICIENCY; REVIEW;

EID: 25844469900     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4266(05)81792-5     Document Type: Review

References (60)

1. Alastair JJ, Wood MD. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996; 335: 179-87.
2. Alton EW, Currie D, Logan-Sinclair R, Warner JO, Hudson ME, Geddes DM. Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J 1990; 3: 922-6.
3. Augarten A, Dubenbaum L, Yahav Y et al. Lunch meal: a single non-invasive challenge test for evaluation of exocrine and endocrine pancreatic function in cystic fibrosis patients. Int J Clin Lab Res. 1999; 29: 114-6.
4. Austin A, Kalhan SC, Orenstein D, Nixon P, Arslanian S. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab 1994; 79: 80-5.
5. Carrington M, Krueger LJ, Holsclaw DS JR, lannuzzi MC, Dean M, Mann D. Cystic fibrosis-related diabetes is associated with HLA DQB1 alleles encoding Asp-57-molecules. J Clin Immunol 1994; 14: 353-8.
6. Cotellessa M, Minicucci L, Diana MC et al. Phenotype/genotype correlation and cystic fibrosis related diabetes mellitus (Italian Multicenter Study). J Pediatr Endocrinol Metab 2000; 13: 1087-93.
7. Couce M, O'Brien TD, Moran A, Roche PC, Butler PC. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab 1996; 81: 1267-72.
8. Cucinotta D, Arrigo T, De Luca, F et al. Metabolic and clinical events preceding diabetes mellitus onset in cystic fibrosis. Eur J Endocrinol 1996; 134: 731-6.
9. Cucinotta D, Conti Nibali S, Arrigo T et al. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res 1990; 34: 33-8.
10. Cucinotta D, De Luca F, Scoglio R et al. Factors affecting diabetes mellitus onset in cystic fibrosis: evidence from a 10-year follow-up study. Acta Paediatr 1999; 88: 389-93.
11. Culler FL, Mckean LP, Buchanan CN, Caplan DB, Meacham LR. Glipizide treatment of patients with cystic fibrosis and impaired glucose tolerance. J Pediatr Gastroenterol Nutr 1994; 18: 375-8.
12. Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades PJ, Sheldon C. Clinical improvement in cystic fibrosis with early insulin treatement. Arch Dis Child 2002; 87: 430-1.
13. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991; 46: 881-5.
14. Fedder J, Cruger D, Oestergaard B, Bruun Petersen G. Etiology of azospermia in 100 consecutive non vasectomized. Fertil Steril 2004; 82: 1463-5.
15. Fluckiger R. Glycosylated Haemoglobin in cystic fibrosis. Arch Dis Child 1988; 63: 223-4.
16. Gilljam M, Antoniou M, Shin J, Dupuis A, Corey M, Tullis DE. Pregnancy in cystic fibrosis. Fetal and maternal outcome. Chest 2000; 118: 85-91.
17. Hamdi I, Green M, Shneerson JM, Palmer CR, Hales CN. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis. Clin Endocrin 1993; 39: 21-6.
18. Hamdi I, Payne SJ, Barton DE et al. Genotype analysis in cystic fibrosis in relation to the occurrence of diabetes mellitus. Clin Genet 1993; 43: 186-9.
19. Hardin DS, Leblanc A, Para L, Seilheimer DK. Hepatic Insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes 1999; 48: 1082-7.
20. Holl RW, Buck C, Babka C, Wolf A, Thon A. HbA1c is not recommended as a screening test for diabetes in cystic fibrosis. Diabetes Care 2000; 23: 126.
21. Holl W, Heinze E, Wolf A, Rank M, Teller WM. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. Eur J Pediatr 1995; 154; 356-61.
22. Ianucci A, Kiyoshi Mukai MD, Johnson D, Burke B. Endocrine pancreas in cystic fibrosis: an immunohistocheminal study. Hum Pathol 1984; 15: 278-84.
23. Jankelson D, Robinson M, Parsons S, Torzillo P, Peat B, Bye P. Cystic fibrosis and pregnancy. Aust N Z J Obstet Gynaecol 1998; 38: 180-4.
24. Kentrup H, Bongers H, Spengler M, Kusenbach G, Skopnik H. Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance. Eur J Pediatr 1999; 158: 455-9.
25. Koch C, Rainisio M, Madessani U et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked ti poor lung function in patients with cystics fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001; 32: 343-50.
26. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 1995; 31: 655-9.
27. Lanng S, Schwartz M, Thorsteinsson B, Koch C. Endocrine and exocrine pancreatic function and the delta F508 mutation in cystic fibrosis. Clin Genet 1991; 40: 345-8.
28. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994; 83: 72-7.
29. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 1994; 83: 849-53.
30. Lanng S, Thorsteinsson B, Pociot F et al. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr 1993; 82: 150-4.
31. Lanng S, Thorsteinsson B, Roder ME, Nerup J, Koch C. Insulin sensitivity ans insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol 1994; 41: 217-23.
32. Lanng S, Thorsteinsson B, Roder ME et al. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol 1993; 128: 207-14.
33. Mackies AD, Thornton SJ, Edenborough FP. Cystic fibrosis-related diabetes. Diabet Med 2003; 20: 425-36.
34. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000; 162: 891-5.
35. Mosnier-Pudar H Diabète de la mucoviscidose: physiopathologie et critères diagnostiques des troubles du métabolisme glucidique. Arch Pediatr 2003; 10: 462-8.
36. Moran A, Hardin D, Rodman D et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999; 45: 61-73.
37. Moran A, Milla C, Ducret R, Nair KS. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance. Diabetes 2001; 50: 136-43.
38. Moran A, Phillips J, Milla C. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care 2001; 24: 1706-10.
39. Moran A, Pyzdrowski KL, Weinreb J et al. Insulin sensitivity in cystic fibrosis. Diabetes 1994; 43: 1020-6.
40. Noussia-Arvanitakis S, Galli-Tsinopolou A, Dracoulacos D, Karamouzis M, Demitriadou A. Islet autoantibiodies and insulin dependent diabetes mellitus in cystic fibrosis. J Pediatr Endoc Metab 2000; 13: 319-24.
41. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouziz M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr 2001; 90: 515-519.
42. Observatoire National de la Mucoviscidose. Rapport sur la situation de la mucoviscidose en France en 1999. Vaincre la mucoviscidose, Institut national d'études démographiques. Paris, mars 2001.
43. Odegaard I, Stray-Pedersen B, Hallberg K, Haanaes OC, Storrosten OT, Johannesson M. Maternal and fetal morbidity in pregnancies of Norwegian and Swedish women with cystic fibrosis. Acta Obstet Gynecol Scand 2002; 81: 698-705.
44. Rakotoambinina B, Delaisi B, Laborde K ef al. Insulin responses to intravenous glucose and the hyperglycemic clamp in cystic fibrosis patients with different degrees of glucose tolerance. Pediatr Res 1994; 36: 667-71.
45. Reisman J, Corey M, Canny G, Levinson H. Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics 1990; 86: 374-7.
46. Rolon MA, Benali K, Munck A et al. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001; 90: 860-7.
47. Rosencker J, Eichler I, Barmeier H, Von der Hardt H. Diabetes mellitus and cystic fibrosis: comparaison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents. Pediatr Pulmonol 2001; 32: 351-5.
48. Rosencker J, Eichler I, Kühn L, Harms HK, Von der Hardt H. Genetic determination of diabetes mellitus in patients with cystic fibrosis. Muticenter Cystic fibrosis Study Group J Pediatr 1995; 127: 441-3.
49. Rosencker J, Hofler R, Steinkamp G et al. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 2001; 27: 345-50.
50. Santis G, Osborne L, Knight RA, Hudson ME. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet 1990; 336: 1081-4.
51. Schaedel C, De Monesterol I, Hjelte L et al. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 2002; 33: 483-91.
52. Stuchfield PR, O' Halloran M, Smith S, Woodrow JC, Batazzo GF, Heaf D. HLA type, islet cell antibodies and glucose intolerance in cystic fibrocis. Arch Dis Childhood 1988; 63: 1234-39.
53. Stuchfield PR, O'Halloran S, Teale JD, Isherwood D, Smith CS, Heaf D. Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child 1987; 62: 805-10.
54. The cystic fibrosis consortium genotype-phenotype. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl. J Med 1993; 329: 1308-1313.
55. Tschopp JM, Brutsche MH, Frey JG et al. End-stage cystic fibrosis: improved diabetes control 2 year after successful isolated pancreatic cell and lung transplantation. Chest 1997; 122: 1685-7.
56. Ward SA, Tomezko JL, Holsclaw DS, Paolone AM. Energy expenditure and substrate utilization in adults with cystic fibrosis and diabetes mellitus. Am J Clin Nutr 1999; 69: 913-9.
57. Wilkin TJ, Stutchfield P, Smith CS, Heaf DP. Autoimmunity, diabetes, and cystic fibrosis. Lancet 1987; 18: 157.
58. Wilson DC, Kalnins D, Stewart C et al. Challenges in the dietary treatment of cystic fibrosis related diabetes mellitus. Clin Nutr 2000; 19: 87-93.
59. Yung B, Kemp M, Hooper J, Hudson M. Random blood glucose alone in the diagnosis of cystic fibrosis related diabetes. Lancet 1997; 349: 619.
60. Yung B, Kemp M, Hooper J, Hodson ME. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria Thorax 1999; 54: 40-3.